February 22 | 2024 2CUREX PUBLISHES INTERIM REPORT FOR THE FOURTH QUARTER AND FULL YEAR OF 2023 AND FINANCIAL AND STRATEGIC OUTLOOK FOR 2024 Read more
October 26 | 2023 Strategy update: Leapfrogging to the decentralization of IndiTreat® testing through full focus on automation Read more
October 11 | 2023 2cureX advances towards IVD-R compliance by securing a contract with a Notified Body Read more
October 3 | 2023 2cureX will be holding its Q3 2023 online presentation with a Q&A session on October 26, 2023 at 20.00 (CET). Read more
August 30 | 2023 2cureX launches its first two IndiTreat® products CE-marked under the new IVD Regulation Read more